Navigation Links
U.S. Bishops: Current Health Care Bills Violate Essential Principles; Will Seek Changes or Have to Oppose
Date:10/9/2009

Bishops' concerns include abortion, conscience, immigrants, affordability

Reaffirm commitment to work for reform that respects life and dignity of all

WASHINGTON, Oct. 9 /PRNewswire-USNewswire/ -- Three chairmen of the bishops' committees working on health care reform urged the U.S. Congress to improve current health care reform legislation, expressing their "disappointment that progress has not been made on the three priority criteria for health care reform" cited in their previous letters.

The October 8 letter from Bishop William Murphy, Cardinal Justin Rigali and Bishop John Wester reiterated the bishops' main concerns: that no one should be forced to pay for or participate in an abortion, that health care should be affordable and available to the poor and vulnerable, and that the needs of legal immigrants are met.

Bishop Murphy, Cardinal Rigali and Bishop Wester chair the U.S. bishops' committees on Domestic Justice and Human Development, Pro-Life Activities and Immigration, respectively.

The bishops reaffirmed their commitment to working with Congress and the Administration toward genuine health care reform, but stated, "If final legislation does not meet our principles, we will have no choice but to oppose the bill."

"We sincerely hope that the legislation will not fall short of our criteria," wrote the bishops. "However, we remain apprehensive when amendments protecting freedom of conscience and ensuring no taxpayer money for abortion are defeated in committee votes."

The United States Conference of Catholic Bishops (USCCB) has advocated for health care reform for decades. The bishops wrote that "Catholic moral tradition teaches that health care is a basic human right, essential to protecting human life and dignity. Much-needed reform of our health care system must be pursued in ways that serve the life and dignity of all, never in ways that undermine or violate these fundamental values. We will work tirelessly to remedy these central problems and help pass real reform that clearly protects the life, dignity and health of all."

The full text of the letter can be found online at:

www.usccb.org/sdwp/national/2009-10-08-healthcare-letter-congress.pdf

Keywords: USCCB, U.S. bishops, United States Conference of Catholic Bishops, health care reform, legislation, House, Senate, U.S. Congress, letter, chairman, Pro-Life, Domestic Justice and Human Development, Immigration, immigrants, the poor, conscience rights, abortion coverage, affordability, oppose

SOURCE U.S. Conference of Catholic Bishops, Secretariat for Pro-Life Activities


'/>"/>
SOURCE U.S. Conference of Catholic Bishops, Secretariat for Pro-Life Activities
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
2. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
3. Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Directors
4. Morris Animal Foundation 2008 Sponsorship Guide Available, Details Current Animal Health Studies
5. Experimental drug boosts survival in recurrent ovarian cancer
6. Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees
7. Stop eating for two: obese moms-to-be should gain less weight than currently recommended
8. Switching to MA Coverage Unlikely for Current Beneficiaries With MediGap or Medicare Only
9. The Current Recall of Boy Scouts of Americas Plastic Badges Does Not Affect Embroidered Insignia, Badges & Awards Produced by Lion Brothers Company Inc.
10. Purified Fish Oil Concentrates Offer Solution to Current Seafood Controversy for Pregnant and Breastfeeding Women!
11. ALEVE-D(R) Sinus & Cold Offers Option for the More Than 50% of Consumers Not Satisfied with Current Sinus Medication
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Yardley, PA (PRWEB) , ... March 23, 2017 ... ... received Patient Oriented Disease Management Accreditation from the NCQA. The accreditation covers StayWell’s ... programs. , Accredited status is granted to organizations that have excellent programs ...
(Date:3/23/2017)... ... , ... The TouchPoint Solution, home of Buzzies *, is boosting the ... , “Buzzies change the way we interact with stress and live our day-to-day lives,” ... date in December 2016, The TouchPoint Solution has sold more than $750,000 in product ...
(Date:3/23/2017)... , ... March 23, 2017 , ... After raising more ... FaceCradle , the most-funded travel pillow in crowdfunding history, has established a ... its wildly popular travel innovation to Americans. , “We’re excited to be operating on ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... today announced rapid completion of the strategic executive team expansion needed to further ... to the ChenMed executive team,” says Christopher Chen, MD, ChenMed Chief Executive Officer. ...
(Date:3/23/2017)... ... March 23, 2017 , ... Natural Subsistence, ... aspects of people’s health and nutrition, announced its product Leyzene is now available ... Subsistence develops nutritional supplements that help people improve all aspects of their health ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... MUMBAI , March 23, 2017 ... de Piramal Enterprises Limited, anuncia el nombramiento de ... PPS ofrece una plataforma de servicios integrados completa ... Needleman desempeñará un cargo clave en el crecimiento ... comercial, Needleman será responsable de impulsar todas las ...
(Date:3/23/2017)... 23, 2017  Galmed Pharmaceuticals Ltd. (Nasdaq: ... clinical-stage biopharmaceutical company focused on the development of ... nonalcoholic steatohepatitis, or NASH, and other liver diseases, ... twelve months ended December 31, 2016, and announced new ... demonstrating Aramchol™,s potential direct effect on liver fibrosis. ...
(Date:3/23/2017)... 23, 2017 ReNeuron reported in December ... in chronic stroke patients, despite not meeting the three-month time ... the Action Research Arm Test (ARAT). As a result, the ... controlled clinical study in 2017. Beyond CTX, we expect safety ... 2017 and Phase I data from its critical limb ischaemia ...
Breaking Medicine Technology: